Who owns VYNE THERAPEUTICS INC?
- Ticker: VYNE
- CUSIP Number: 92941v308
Tip: Access positions for across all investors
Analyze quarterly positions in Vyne Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Vyne Therapeutics stock
Who bought or sold VYNE THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Cormorant Asset Management | 1.4M | $2.6M | 0% | Sep 2024 |
|
Eventide Asset Management | 1.4M | $3.1M | 0% | Sep 2024 |
|
Citadel Advisors | 1.2M | $2.2M | -2% | Sep 2024 |
|
DSC Advisors | 697k | $1.3M | 0% | Sep 2024 |
|
Palo Alto Investors | 445k | $837k | 0% | Sep 2024 |
|
Vanguard Group | 444k | $834k | 0% | Sep 2024 |
|
Exome Asset Management | 353k | $665k | 0% | Sep 2024 |
|
Parkman Healthcare Partners | 203k | $382k | -41% | Sep 2024 |
|
Schonfeld Strategic Advisors | 169k | $317k | -22% | Sep 2024 |
|
ADAR1 Capital Management | 153k | $287k | -11% | Sep 2024 |
|
Geode Capital Management | 135k | $253k | -1% | Sep 2024 |
|
Renaissance Technologies | 87k | $163k | 37% | Sep 2024 |
|
BlackRock | 83k | $279k | 0% | Dec 2024 |
|
Silverarc Capital Management | 77k | $144k | -84% | Sep 2024 |
|
Springbok Capital Management | 65k | $123k | 0% | Sep 2024 |
|
Susquehanna International | 60k | $114k | 0% | Sep 2024 |
|
Northern Trust | 37k | $70k | 100% | Sep 2024 |
|
XTX Topco | 21k | $70k | 100% | Dec 2024 |
|
Commonwealth Equity Services | 18k | $61k | 0% | Dec 2024 |
|
Lynx1 Capital Management | 16k | $30k | 0% | Sep 2024 |
|
State Street Corporation | 16k | $30k | 0% | Sep 2024 |
|
BFSG | 3.5k | $12k | 100% | Dec 2024 |
|
Royal Bank of Canada | 2.4k | $5.0k | -45% | Sep 2024 |
|
Bank of America Corporation | 2.3k | $4.3k | -1% | Sep 2024 |
|
Tower Research Capital | 1.4k | $4.6k | -37% | Dec 2024 |
|
Centerpoint Advisors | 350.00 | $999.985000 | 0% | Dec 2024 |
|
Russell Investments | 187.00 | $350.999000 | 0% | Sep 2024 |
|
Jpmorgan Chase & Co | 177.00 | $332.193600 | 1% | Sep 2024 |
|
Barclays | 100.00 | $0 | 100% | Sep 2024 |
|
Wells Fargo & Company | 65.00 | $121.998500 | 0% | Sep 2024 |
|
UBS Group | 14.00 | $25.999400 | -100% | Sep 2024 |
|
Who sold out of Vyne Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
AlphaCentric Advisors | Sep 2024 | 269k | $505k |